JENNIFER HALL: Open Payments
NPI 1225188220 · DUNLAP, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 12 payments from 7 companies in 2025. Trend: 2023 $346 · 2024 $265 · 2025 $212
Food & beverage: $189Education: $23
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 5 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Novo Nordisk Inc | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: YUPELRI, Kerendia, BREZTRI, Ozempic, XIFAXAN, JOURNAVX, MOUNJARO.
Industry payments across IA — which companies pay providers there.
